市場調查報告書
商品編碼
1291357
銀質傷口敷料市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Silver Wound Dressing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球銀質傷口敷料的市場規模在2022年達到9.283億美元。展望未來,IMARC Group預計到2028年市場規模將達到12.298億美元,在2023-2028年期間表現出4.5%的成長率(CAGR)。
銀質傷口敷料指的是局部傷口護理產品,它向傷口釋放穩定數量的銀,以提供抗菌和抗細菌作用。它們以屏障層、炭布敷料、泡沫敷料和水膠體的形式廣泛存在。銀質敷料可作為主要或輔助敷料,用於處理急性和慢性傷口的少量、中等或大量滲出物,如手術傷口、燒傷、壓迫性潰瘍、腿部潰瘍和糖尿病足潰瘍。它們也可以在壓迫下使用,或與特定的局部和輔助療法一起使用,以減少細菌負荷,遏制滲出物,並改善傷口肉芽組織的外觀。近年來,銀質傷口敷料在醫療保健行業獲得了巨大的普及,用於治療有局部感染或生物負擔風險的急性或慢性傷口。
銀質傷口敷料有助於預防和減少感染,提供廣泛的抗菌活性,並改變傷口內的金屬蛋白酶。因此,銀質傷口敷料正在迅速取代傳統的傷口護理和封閉產品,這也是推動市場成長的主要因素。除此之外,慢性傷口和燒傷發病率的上升,以及人們對先進的傷口護理治療的認知的提高,都催化了對銀製傷口敷料的需求。此外,癌症、糖尿病和心血管疾病(CVDs)等慢性病的發病率也有明顯增加。與此同時,越來越多的病人接受手術,鼓勵採用銀質傷口敷料,以防止手術部位感染,促進傷口快速癒合。此外,一些關鍵的參與者正在進行大量投資,推出新的和創新的銀質傷口敷料變體,以擴大他們的產品組合併獲得競爭優勢。其他因素,包括新興的家庭保健趨勢、道路事故案例的增加、人口老齡化、醫療保健基礎設施的改善、技術進步和廣泛的研究和開發(R&D)活動,也為市場成長提供了積極的推動力。
The global silver wound dressing market size reached US$ 928.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,229.8 Million by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2023-2028.
Silver wound dressings refer to topical wound care products that release a steady amount of silver to the wound to provide antimicrobial and antibacterial action. They are widely available in the form of barrier layers, charcoal cloth dressings, foam dressings, and hydrocolloids. Silver dressings can be used as primary or secondary dressings to manage minimal, moderate, or heavy exudate in acute and chronic wounds, such as surgical wounds, burns, pressure ulcers, leg ulcers, and diabetic foot ulcers. They can also be utilized under compression or with select topical and adjunctive therapies to reduce the bacterial load, contain exudate, and improve the appearance of the wound's granulation tissue. In recent years, silver wound dressings have gained immense popularity in the healthcare industry to treat acute or chronic wounds with or at risk of local infection or bioburden.
Silver wound dressings help prevent and reduce infections, provide a wide range of antimicrobial activity, and alter metalloproteinases within wounds. As a result, silver wound dressings are rapidly replacing traditional wound care and closure products, which represents the primary factor driving the market growth. Besides this, the rising incidences of chronic wounds and burns and the growing awareness regarding advanced wound care treatment are catalyzing the demand for silver wound dressings. Additionally, there has been a significant increase in the prevalence of chronic conditions, such as cancer, diabetes, and cardiovascular diseases (CVDs). Along with this, the increasing number of patients undergoing surgeries is encouraging the adoption of silver wound dressings to prevent surgical site infections and promote faster wound healing. Furthermore, several key players are making heavy investments to launch new and innovative silver wound dressing variants to expand their product portfolio and gain a competitive edge. Other factors, including the emerging trend of home healthcare, rising cases of road accidents, aging population, improving healthcare infrastructure, technological advancements, and extensive research and development (R&D) activities, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global silver wound dressing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease and end user.
Hydrofiber Silver Dressings
Nanocrystalline Silver Dressing
Silver Plated Nylon Fiber Dressing
Silver Nitrate Dressing
Silver Alginate Dressing
Others
Ulcers
Burns
Cuts and Lacerations
Others
Inpatient Facilities
Outpatient Facilities
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, ConvaTec Group plc, Ferris Mfg. Corp., Hollister Incorporated, Integra LifeSciences, Medline Industries LP, Molnlycke Health Care AB and Smith & Nephew plc.